BEGIN:VCALENDAR
VERSION:1.0
BEGIN:VEVENT
SUMMARY;ENCODING=QUOTED-PRINTABLE:Cambridge biogerontologist Aubrey de Grey=3A =22Why the prospect of dramatic life extension matters now=22
DESCRIPTION;ENCODING=QUOTED-PRINTABLE:=22Many people say curing aging might be a bad idea=2C but deep down we all know that=27s nonsense=2E  We cling to silly doubts about it only because we don=27t want to get our hopes up too soon=2E  Eventually=2C though=2C this will stop being appropriate=3A we=27ll know enough to wage a =27war on aging=27 with a fair chance of winning it in a few decades=2E At that time=2C ambivalence will cost lives - 100=2C000 lives each day - by slowing down the research and development to turn our knowledge into working rejuvenation therapies=2E  I will explain that we have recently reached that point=3A the time for the war on aging has arrived=2E=22 - Aubrey de Grey=0D=0DWith the Baby Boomer generation aging and the current rapid advances in biotechnology and medicine=2C aging will soon come to the forefront of the public consciousness=2E Do not miss this rare opportunity to hear from a leading biogerontologist of worldwide repute=2E=0D=0DAs of 2005=2C de Grey=27s current work at Cambridge centered around a detailed plan called Strategies for Engineered Negligible Senescence =28SENS=29 which is aimed at preventing age-related physical and cognitive decline=2E He is also the co-founder and chief scientist of the Methuselah Mouse Prize=2C a prize designed to accelerate research into effective life extension interventions by awarding monetary prizes to researchers who extend the lifespan of mice to unprecedented lengths=2E He has been interviewed in recent years in many news sources=2C including the BBC=2C the New York Times=2C Fortune Magazine=2C and Popular Science=2E
LOCATION;ENCODING=QUOTED-PRINTABLE:Clark Center Auditorium
DTSTART:20050609T020000Z
DTEND:20050609T030000Z
END:VEVENT
END:VCALENDAR